SCHEMBL24341585

SCHEMBL24341585

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)oc5c7ccccc7c7c8ccccc8oc7c65)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.37
▸ CYP1B1 Q16678 1/20 0.37
▸ HCRTR1 O43613 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ ESR1 P03372 2/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ LPL P06858 1/20 0.34
▸ LIPG Q9Y5X9 1/20 0.34
▸ ALOX5 P09917 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ ALPI P09923 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24341729 0.94 HCRTR1 (0.38) CYP1A1CYP1B1HCRTR1L3MBTL1TDP1
SCHEMBL17943904 0.94 CYP1A1 (0.39) CYP1A1CYP1B1HCRTR1L3MBTL1TDP1
SCHEMBL24341584 0.94 CYP1A1 (0.39) CYP1A1CYP1B1HCRTR1L3MBTL1TDP1
SCHEMBL17246956 0.94 CYP1A1 (0.39) CYP1A1CYP1B1HCRTR1L3MBTL1TDP1
SCHEMBL24342818 0.93 HCRTR1 (0.37) CYP1A1CYP1B1HCRTR1L3MBTL1TDP1
SCHEMBL24341241 0.93 NPC1 (0.37) CYP1A1CYP1B1L3MBTL1TDP1ESR1
SCHEMBL17944695 0.91 CYP1A1 (0.38) CYP1A1CYP1B1HCRTR1L3MBTL1TDP1
SCHEMBL19109813 0.91 ALOX5 (0.38) CYP1A1CYP1B1HCRTR1L3MBTL1TDP1
SCHEMBL13508220 0.91 CYP1A1 (0.41) CYP1A1CYP1B1HCRTR1L3MBTL1TDP1
SCHEMBL17122589 0.90 CYP1A1 (0.37) CYP1A1CYP1B1HCRTR1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885HCRTR1 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback